Medicine and Dentistry
Patient
100%
Percutaneous Coronary Intervention
87%
Inpatient
68%
Combination Therapy
43%
Drug-Eluting Stent
42%
Antiplatelet
37%
Analysis
24%
Acute Coronary Syndrome
24%
Lesion
23%
Myocardial Infarction
23%
Hazard Ratio
22%
Stent
20%
Coronary Artery Disease
18%
Clopidogrel
17%
Follow up
15%
Monotherapy
15%
Acetylsalicylic Acid
13%
Stenting
13%
Revascularization
12%
Diabetes Mellitus
12%
Atrial Fibrillation
11%
Prasugrel
10%
Antithrombotic
10%
Association
9%
ST Segment Elevation Myocardial Infarction
9%
Percutaneous Aortic Valve Replacement
9%
Bleeding
9%
Acute Heart Infarction
9%
Intravascular Ultrasound
9%
Stent Thrombosis
9%
Meta-Analysis
8%
Antithrombotic Therapy
8%
Target Lesion
8%
Heart Death
7%
Cause of Death
7%
Patient with Diabetes
7%
Randomized Clinical Trial
7%
Coronary Bifurcation Lesion
7%
Fractional Flow Reserve
7%
Mortality
7%
Platelet Reactivity
6%
Target Lesion Revascularization
6%
Chronic Kidney Disease
6%
Chronic Total Occlusion
6%
In-Stent Restenosis
6%
Heart Failure
6%
Incidence
6%
Platelet
6%
Post-Hoc Analysis
5%
Drug
5%
Pharmacology, Toxicology and Pharmaceutical Science
Anticoagulant Agent
21%
Stent
17%
Drug
11%
Acute Coronary Syndrome
11%
Heart Infarction
11%
Clopidogrel
8%
Atrial Fibrillation
8%
Coronary Artery Disease
7%
Prasugrel
7%
Monotherapy
7%
Bleeding
6%
Sirolimus
6%
Cause of Death
6%
Acute Heart Infarction
5%
ST Segment Elevation Myocardial Infarction
5%